Therefore, the situation in which locally advanced GC has abundant PD-L1 expression similar to late-stage GC is supported by our data and provides a solid theoretical foundation for neoadjuvant immunotherapy or perioperative immunotherapy. This evidence concerns the gene CD274 and gastric cancer.